Now showing items 1-5 of 5
Upper-Extremity Deep-Vein Thrombosis: A Retrospective Cohort Evaluation of Thrombotic Risk Factors at a University Teaching Hospital Antithrombosis Clinic.
(Sage Publications, 2016-08)
BACKGROUND: Upper-extremity deep-vein thrombosis (UEDVT) causes significant morbidity and mortality and is not well characterized in the existing literature, particularly in underrepresented minorities such as African ...
Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial.
AIMS:Many patients with heart failure and reduced EF remain at high risk for hospitalization despite evidence-based therapy. Digoxin may decrease hospitalization; however, uncertainty persists concerning its proper ...
Xing, S., Sharp, L. K. and Touchette, D. R. Weight loss drugs and lifestyle modification: Perceptions among a diverse adult sample. Patient Education and Counseling. 2016. DOI: 10.1016/j.pec.2016.11.004.
Objectives: Explore how adults from diverse racial and socioeconomic backgrounds perceive the use of weight loss drugs (prescription, over-the counter, herbals and supplements) and lifestyle modification. Methods: Individual, ...
Respiratory and bronchitic symptoms predict intention to quit smoking among current smokers with and at risk for COPD
(American Thoracic Society, 2016-09)
RATIONALE: Smoking cessation is the most important intervention for patients with chronic obstructive pulmonary disease (COPD). What leads smokers with COPD to quit smoking remains unknown. OBJECTIVES: We sought to ...
Top-down versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease.
(Lippincott, Williams & Wilkins, 2016-10)
BACKGROUND: Early initiation of tumor necrosis factor-alpha inhibitor (TNFI) therapy for children and young adults with inflammatory bowel disease (IBD) is not well described. METHODS: We conducted a retrospective cohort ...